Recent Updates
Recently added Catalysts
RGC

FORM OF LETTER OF LOCK-UP UNDERTAKING Date: From: (the " Optionee ") To: Regencell Bioscience Holdings Limited (the " Company ") References are made in this third extension of letter of lock-up undertaking (this " Third

Key Takeaway: Regencell Bioscience Holdings Limited has announced a third extension of a lock-up undertaking, extending the period during which certain options and shares cannot be sold. The extension will last for an additional twelve months, effective until January 20, 2025. This extension reinforces the company's efforts to maintain market stability and manage share distribution following their initial public offering. The agreement is governed by New York laws, ensuring consistency in interpretation and enforcement.

Market Sentiment Analysis

Full Press Release Details

FORM OF LETTER OF LOCK-UP UNDERTAKING
Date:
From: (the " Optionee ")
To: Regencell Bioscience Holdings Limited (the " Company ")
References are made in this
third extension of letter of lock-up undertaking (this "Third Extension of Lock-Up Undertaking") to (i) an agreement
of option to purchase ordinary share of Regencell Bioscience Holdings Limited dated , under which the Company granted certain options
(the "Options") to purchase ordinary shares of the Company in the amounts set forth therein; (ii) a letter of lock-up
undertaking by the Optionee dated , under which the Optionee undertook to the Company, within the period of one year and six months
immediately following the closing of the initial public offering of the Company, not to, and to procure any entities controlled by the
Optionee and any trusts of which the Optionee is a beneficiary not to, offer, pledge, sell, contract to sell, sell any option or contract
to purchase, purchase any option or contract to sell, grant any option, right or warrant for the sale of, or otherwise transfer or dispose
of any of the Options or shares issued upon exercise of the Options (the "Lock-Up Undertaking"); (iii) a letter of
lock-up undertaking by the Optionee dated , under which the Optionee undertook to the Company to extend the Lock-Up Undertaking for
an additional six months (the "First Extension of the Lock-Up Undertaking"); and (iv) a letter of lock-up undertaking
by the Optionee dated , under which the Optionee undertook to the Company to extend the Lock-Up Undertaking and the First Extension
of the Lock-Up Undertaking for an additional six months (the "Second Extension of the Lock-Up Undertaking", and together
with the Lock-Up Undertaking and the First Extension of the Lock-Up Undertaking, the "Lock-Up Undertakings").
For good and valuable consideration
received by the Optionee from the Company, the Optionee hereby agrees to enter into this Third Extension of Lock-Up Undertaking to extend
the Lock-Up Undertakings for an additional twelve months until January 20, 2025.
The laws of New York shall govern the interpretation,
validity, administration, enforcement and performance of the terms of this Third Extension of Lock-Up Undertaking regardless of the law
that might be applied under principles of conflicts of laws.
[The remainder of this page is intentionally left
IN WITNESS WHEREOF, the Optionee has executed this letter agreement
as of the date first set forth above.
Regencell Bioscience Holdings Limited
Yat-Gai Au
Chief Executive Officer
[Signature Page to the Letter of Lock-up Undertaking]

Frequently Asked Questions

What is the purpose of the lock-up undertaking?

The lock-up undertaking restricts the Optionee from selling or transferring shares for a specified period.

How long is the third extension of the lock-up undertaking?

The third extension lasts an additional twelve months, until January 20, 2025.

Who governs the terms of the lock-up undertaking?

The laws of New York govern the interpretation and performance of the lock-up undertaking.

What options are involved in the lock-up undertaking?

The options pertain to purchasing ordinary shares of Regencell Bioscience Holdings Limited.

Last updated: Dec 15, 2023